J Biol Chem, Vol. 274, Issue 12, 8191-8198, March 19, 1999
Antisense Oligonucleotides Containing Modified Bases Inhibit
in Vitro Translation of Leishmania
amazonensis mRNAs by Invading the Mini-exon
Hairpin
Daniel
Compagno
,
Jed N.
Lampe§,
Chantal
Bourget
,
Igor V.
Kutyavin§,
Ludmila
Yurchenko¶,
Eugeny A.
Lukhtanov§,
Vladimir
V.
Gorn§,
Howard B.
Gamper Jr.§, and
Jean-Jacques
Toulmé
From
INSERM Unité 386, IFR Pathologies
Infectieuses, Université Victor Segalen, 146 rue Léo
Saignat, 33076 Bordeaux, France, § Epoch Pharmaceuticals,
Inc., Bothell, Washington 98021, and the ¶ Institute of Biorganic
Chemistry, Lavrentiev Prospekt 8, Novosibirsk, Russia
Complementary oligodeoxynucleotides (ODNs) that
contain 2-aminoadenine and 2-thiothymine interact weakly with each
other but form stable hybrids with unmodified complements. These
selectively binding complementary (SBC) agents can invade duplex DNA
and hybridize to each strand (Kutyavin, I. V., Rhinehart, R. L., Lukhtanov, E. A., Gorn, V. V., Meyer, R. B., and
Gamper, H. B. (1996) Biochemistry 35, 11170-11176).
Antisense ODNs with similar properties should be less encumbered by RNA
secondary structure. Here we show that SBC ODNs strand invade a hairpin
in the mini-exon RNA of Leishmania amazonensis and that the
resulting heteroduplexes are substrates for Escherichia
coli RNase H. SBC ODNs either with phosphodiester or
phosphorothioate backbones form more stable hybrids with RNA than
normal base (NB) ODNs. Optimal binding was observed when the entire
hairpin sequence was targeted. Translation of L. amazonensis mRNA in a cell-free extract was more efficiently
inhibited by SBC ODNs complementary to the mini-exon hairpin than by
the corresponding NB ODNs. Nonspecific protein binding in the cell-free
extract by phosphorothioate SBC ODNs rendered them ineffective as
antisense agents in vitro. SBC phosphorothioate ODNs
displayed a modest but significant improvement of leishmanicidal
properties compared with NB phosphorothioate ODNs.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.